Nasopharyngeal carcinoma: Introduction

Nasopharyngeal carcinoma: A malignant cancer that occurs in the nasopharynx area which is the upper part of the throat. Often there are no symptoms until the cancer has metastasized to other parts of the body such as the neck.
More detailed information about the symptoms,
causes, and treatments of Nasopharyngeal carcinoma is available below.

Definitions of Nasopharyngeal carcinoma:

Nasopharyngeal carcinomas are nonglandular carcinomas that arise in the nasopharynx. Nasopharyngeal carcinomas are very common in the Orient. Initial complaints are often due to middle-ear obstruction (otitis, hearing loss) or local invasion (headache, cranial nerve deficits). At least half of the patients with undifferentiated nasopharyngeal carcinoma are seen with cervical lymph node metastasis from an occult primary. The nasopharyngeal carcinomas are subtyped as keratinizing squamous cell carcinoma, nonkeratinizing carcinoma and undifferentiated carcinoma. Squamous cell carcinoma and nonkeratinizing carcinoma mainly develop in adults and are rare in childhood. In contrast, undifferentiated carcinoma often occurs in children and shows a bimodal age distribution, with peaks in the second and sixth decades. All forms of nasopharyngeal carcinoma occur more frequently in males. Nasopharyngeal carcinoma is treated with radiation. Keratinizing squamous carcinomas are least radiation sensitive and have the poorest prognosis. Nonkeratinizing carcinomas have a survival rate intermediate between keratinizing and undifferentiated carcinomas or they behave like undifferentiated carcinomas. In several large series of cases treated with radiation, undifferentiated carcinoma had the following 5-year survival rates, according to stage: stage I: 50% to 60%; stage II: 20% to 30%; and stage III:5% to 20% (Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999). --2002
- (Source - Diseases Database)

Nasopharyngeal carcinoma is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Nasopharyngeal carcinoma, or a subtype of Nasopharyngeal carcinoma,
affects less than 200,000 people in the US population.
Source - National Institutes of Health (NIH)

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.